13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
|
Name |
WKN |
Börse |
Kurs |
Datum/Zeit |
Diff. |
Diff. % |
Geld |
Brief |
Erster |
Schluss |
![](/mel/img/quote_button.gif) |
SANOFI SA INHABER EO 2 |
920657 |
Frankfurt |
87,870 |
18.06.24 09:35:40 |
+0,620 |
+0,71% |
0,000 |
0,000 |
87,640 |
87,250 |
![](/mel/img/quote_button.gif) |
REGENERON PHARMAC.DL-,001 |
881535 |
Frankfurt |
969,600 |
18.06.24 08:14:43 |
-6,200 |
-0,64% |
0,000 |
0,000 |
969,600 |
975,800 |